Safi, B., Kanjou, M., De Olyveira, G., Basmaji, P. and Guastaldi A.C. (2022) Nanoskin?—The Impact of Natural Membrane on COVID-19 and Chronic Wound. Journal of Community Medicine and Public Health Reports, 3, 1-11.

has been cited by the following article:

• TITLE: Natural Nanoskin Advanced Cell Therapy (ACT) and Nanoskin ACT Soft towards the Definitive Solution for Acute and Chronic Wounds

  AUTHORS: Saqer Al Mualla, Noura Salim Salman, Nasreen Abdelatif, Salma Al Ketbi, Pierre Basmaji, Mohamed Kanjou, Mirvan Ahmad

  KEYWORDS: Wound Care, Diabetic Ulcer, Natural Fibers

  JOURNAL NAME: Journal of Biomaterials and Nanobiotechnology, Vol.14 No.2, April 24, 2023

  ABSTRACT: Natural Nanoskin Advance cell therapy (ACT) and Nanoskin ACT Soft have been established to be remarkably versatile biomaterials and can be used in a wide variety of applied scientific endeavors, especially for medical devices. In fact, the structure of Nanoskin materials can be adapted over length scales ranging from nano to macro by controlling the bio-fabrication process. The present paper describes Natural Nanoskin Advanced cell therapy (ACT) and Nanoskin ACT Soft production for wound care applications. ACT is produced from the bio-nanotechnology process. ACT is a highly hydrated pellicle with shaped fibers less than 2 nm wide. Nanoskin ACT Soft, like a paste, is designed to fill irregularities or recesses in the wound bed, and to absorb excess exudate from lesions by prolonging the used dressing's residence time and reducing the frequency of change.